Tag - pharmaceutical

 
 

PHARMACEUTICAL

Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
BUSINESS / Companies
Dec 17, 2018
Taisho said to near $1.6 billion deal for Bristol-Myers unit
Taisho Pharmaceutical Holdings Co. is nearing a deal to buy Bristol-Myers Squibb Co.'s French over-the-counter unit, people familiar with the matter said, as the Japanese drugmaker seeks to boost its overseas presence.
Japan Times
Rugby / RWC Countdown
Sep 19, 2018
Uehara finds common thread between rugby and business
Akira Uehara, the president of longtime rugby national team sponsor Taisho Pharmaceutical Co., Ltd., played in the front row for Keio University's B.Y.B Rugby Football Club in the 1960s.
BUSINESS
Jul 18, 2018
China heart drug sold globally may have had cancer-linked impurity since 2012
A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.
BUSINESS / Companies
May 23, 2017
Deal for U.S. drugmaker Upsher-Smith Laboratories poised to boost sales for Sawai
For decades, the Sawai family was content to keep the drug business it founded focused on the Japanese market. Now, it is steering the country's second-biggest maker of generic drugs through its first overseas acquisition in its 88-year history.
BUSINESS / Companies
Jan 4, 2017
Ono Pharma's wild 2016 ride cuts stock valuation by ¥1.87 trillion
The rise and fall of Ono Pharmaceutical Co. in 2016 was a tale of two halves, and one drug.
BUSINESS
Nov 1, 2016
Pharma, aerospace industries seek Brexit assurances after Nissan deal
Britain's pharmaceutical and aerospace industries, both big exporters, are stepping up pressure on the government for assurances about their future after last week's post-Brexit deal with carmaker Nissan.
BUSINESS / Companies
Feb 21, 2016
Japan's Sosei sees more tie-ups with international drugmakers in the pipeline
Japan's Sosei Group Corp., which has seen its stock triple over the past year on tie-ups with international companies, could enter into more partnerships in 2016 to develop new medicines and diversify beyond its main lung disease treatment.
CULTURE / TV & Streaming / CHANNEL SURF
Mar 6, 2015
Home design; Pacific war; CM of the week: Taisho Pharmaceutical
TV Asahi's "Before/After" (Sun., 6:57 p.m.) is single-handedly responsible for the "reform boom." The show has inspired thousands of families to remodel their homes into something more livable and aesthetically pleasing.
Japan Times
COMMENTARY / World
Nov 14, 2014
Battle against Ebola raises ethical questions
The tiny number of Ebola cases in rich countries — and the ensuing panic-inducing headlines and quarantine measures — have brought home the global nature of infectious disease today.
EDITORIALS
Oct 23, 2014
The quasi-legal drug dilemma
There is no end in sight to the traffic accidents and other incidents attributed to the use of quasi-legal — or what the police now call 'dangerous' — drugs. It's not easy revising the laws regulating their use.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?